U.S. Patent Office Enablement Guidelines in View of Supreme Court Amgen v. Sanofi Decision
The U.S. Patent Office has published updated examination guidelines regarding the enablement requirement in view of the Supreme Court’s May 2023 decision in Amgen v. Sanofi. The guidelines generally reiterate that (1) enablement… more